Turning portfolio evidence into investment decisions
Challenge: A pharmaceutical portfolio needed coordinated recommendations across brands, channels and specialist teams, with clear budget accountability.
Michelle’s role: Senior agency client adviser, leading integrated briefings, investment scenario planning, scope management and budget reconciliation.
Approach: Michelle translated cross-channel performance and HCP engagement signals into investment reallocation and optimization recommendations. She brought strategy, communications planning, partnerships and analytics together around audience priorities and budget choices.
Delivered: Portfolio investment scenarios, reconciled budgets and unified recommendations for senior stakeholders.
Evidence boundary: This demonstrates documented strategy and advisory work; no quantified savings, campaign lift or prescribing outcome is claimed.